What should I avoid while taking Synthroid? Do not change brands or change to a generic levothyroxine drug product without first asking your doctor. Thyroid hormones do not readily cross the placental barrier (see PRECAUTIONS - Pregnancy). How is Synthroid Supplied Synthroid (levothyroxine sodium tablets, USP) are round, color coded, scored and debossed with "Synthroid" on one side and potency on the other side. Blood and urine tests will be needed to check for unwanted effects . Levothyroxine should not be used for the treatment of obesity or for the bloating synthroid of losing bloating synthroid
synthroid blood sugar
If you have bloating synthroid about side effects, contact your health care provider. 10 Aluminum Lake, FD&C Yellow No. Incorrect use of Synthroid may cause serious and sometimes fatal side effects. Maternal hypothyroidism may have an adverse effect on fetal and childhood growth and development. See full prescribing information for dosage and administration. Cerebral embolism, shock, coma, and death have been reported. Do not stop or change your dose of Synthroid without first checking with your doctor. --Storage instructions... 6 Product Characteristics Color ORANGE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;25 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-4341-13 100 TABLET In 1 BOTTLE None 2 0074-4341-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-4552 Route of Administration ORAL DEA Schedule Active Ingredient/Active bloating synthroid Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 50 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC Product Characteristics Color WHITE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;50 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-4552-13 100 TABLET In 1 BOTTLE None 2 0074-4552-19 1000 TABLET In 1 BOTTLE None 3 0074-4552-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a bloating synthroid PACK 3 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-4552-11) 4 0074-4552-71 28 TABLET In 1 BOX None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-5182 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 75 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C RED NO. Soybean flour (infant formula), cotton seed meal, walnuts, and bloating synthroid fiber bloating synthroid bind and decrease the absorption of levothyroxine sodium from the GI tract. If your brand may cause these effects, be sure to take your medicine with a full glass of water. Women taking daily doses of 1.6 mcg/kg or more had significantly lower bone mineral density levels at the ultradistal radius, midshaft radius, hip, and lumbar spine compared to controls. Dispense in a tight, lightresistant container as described in USP. Dermatologic Dermatologic side effects including transient dermatologic effect and hair loss have been reported during the initial months of therapy. 1 Aluminum Lake 150 FD&C Blue No. The patient should be monitored closely to avoid undertreatment or overtreatment. Excessive doses of Synthroid in infants may cause the top of the skull to close too early.
Package Label.Principal Display Panel NDC 0074-6624-13 100 TABLETS bloating synthroid (levothyroxine sodium tablets, USP) 100 mcg (0.1 mg) Rx only NSN 6505-01-340-0152 Do not accept if seal over bottle opening is broken or missing. TSH may not normalize due to a resetting of the pituitary-thyroid feedback threshold as a result of in utero hypothyroidism. You should not use this bloating synthroid if you have had a heart attack, a thyroid disorder called thyrotoxicosis, or an adrenal gland problem that is not controlled by treatment. If you use insulin or take diabetes medicine by mouth, ask your doctor if your dose needs to be changed when you start using Synthroid. Your doctor may occasionally change your dose to make sure you get the best results. Overtreatment with levothyroxine sodium may have adverse cardiovascular effects such as an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias. In addition, the efficacy of TSH bloating synthroid for benign nodular disease is controversial. Digitalis glycosides The therapeutic effects of digitalis glycosides may be reduced by levothyroxine. Synthroid is contraindicated bloating synthroid patients with hypersensitivity to any of the inactive ingredients in Synthroid tablets (See DESCRIPTION - Inactive Ingredients ). You may report side effects to the FDA at 1-800-FDA-1088. The information contained in the bloating synthroid Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is very important to take levothyroxine with a full glass (8 ounces) of water. Overtreatment with levothyroxine sodium may have adverse cardiovascular effects such as an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias. Ischemic heart disease and significant effects on cardiac function including an increased incidence of premature bloating synthroid beats, an increased left bloating synthroid mass index, and enhanced left ventricular systolic function have been reported in clinical trials.